Arbutus Biopharma Corporation
ABUS
$2.98
$0.093.11%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.57% | -6.09% | -12.00% | 3.92% | -0.13% |
| Total Receivables | 54.22% | -18.19% | -16.95% | -19.91% | 141.42% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -8.36% | -19.18% | 41.98% | 29.35% | -0.42% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.91% | -6.77% | -10.83% | 3.89% | 1.13% |
|
|
|||||
| Total Current Assets | 2.91% | -6.77% | -10.83% | 3.89% | 1.13% |
| Net Property, Plant & Equipment | -5.73% | -6.81% | -6.04% | 6.70% | -4.34% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -72.73% | -82.26% | -39.81% |
| Total Assets | 4.08% | -8.98% | -10.28% | -7.53% | -2.15% |
|
|
|||||
| Total Accounts Payable | 16.13% | 42.61% | 116.48% | -57.47% | -30.26% |
| Total Accrued Expenses | -36.10% | -6.60% | -2.77% | 7.82% | -42.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.12% | 3.16% | 3.78% | -10.99% | 19.89% |
| Total Finance Division Other Current Liabilities | -2.07% | -2.60% | -21.02% | 1.81% | -8.51% |
| Total Other Current Liabilities | -2.07% | -2.60% | -21.02% | 1.81% | -8.51% |
| Total Current Liabilities | -9.74% | 0.73% | -8.99% | -2.48% | -23.44% |
|
|
|||||
| Total Current Liabilities | -9.74% | 0.73% | -8.99% | -2.48% | -23.44% |
| Long-Term Debt | -8.01% | -14.27% | -7.70% | -6.36% | -9.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.06% | -10.29% | -9.05% | -1.50% | -7.93% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.37% | 3.08% | 2.86% | -35.42% | -17.96% |
| Total Liabilities | -7.11% | -2.34% | -6.71% | -10.95% | -19.22% |
|
|
|||||
| Common Stock & APIC | 1.85% | 0.39% | 0.29% | 0.55% | 1.62% |
| Retained Earnings | -1.40% | -1.54% | -1.62% | -1.40% | -1.36% |
| Treasury Stock & Other | 0.10% | 0.95% | 1.18% | 0.33% | 1.69% |
| Total Common Equity | 8.13% | -11.16% | -11.40% | -6.41% | 5.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.13% | -11.16% | -11.40% | -6.41% | 5.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.13% | -11.16% | -11.40% | -6.41% | 5.16% |
|
|
|||||
